CAS 63968-82-1

3-amino-4-[[1-[2-[[5-amino-1-[[2-[[2-[[4-amino-1-[[1-benzyl-2-[[1-[[2-[[1-[(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]amino]-4-oxo-butanoic acid 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid 63968-82-1

纯度 97%+现货药物标准品
CAS 号63968-82-1
分子式C59H95N15O18S
分子量1334.54 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

3-amino-4-[[1-[2-[[5-amino-1-[[2-[[2-[[4-amino-1-[[1-benzyl-2-[[1-[[2-[[1-[(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]amino]-4-oxo-butanoic acid 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid 63968-82-1 CAS 63968-82-1 结构式 Chemical Structure

产品介绍 Description

（3-amino-4-[[1-[2-[[5-amino-1-[[2-[[2-[[4-amino-1-[[1-benzyl-2-[[1-[[2-[[1-[(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]amino]-4-oxo-butanoic acid 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid 63968-82-1）是药物分析与质量控制领域常用的药物标准品，CAS 号 63968-82-1。分子式 C59H95N15O18S，分子量 1334.54。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

本品适用于HPLC、GC、LC-MS/MS、GC-MS等主要色谱平台的定量分析，可作为外标法校准标准品或系统适用性测试参考物质使用。 CAS编号 63968-82-1 对应的化合物（英文标识 3-amino-4-1-2-5-amino-1-2-2-4-amino-1-1-benzyl-2-1-2-1-(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl-3-methyl-butylamino-2-oxo-ethylcarbamoyl-2-methyl-propylamino-2-oxo-ethylcarbamoyl-4-oxo-butylamino-1-(carboxymethyl)-2-oxo-ethylamino-1-(hydroxymethyl)-2-oxo-ethylcarbamoylpentylcarbamoylpyrrolidine-1-carbonyl-2-methyl-propylamino-4-oxo-butanoic ac

应用场景：（3-amino-4- 1- 2- 5-amino-1- 2- 2- 4-amino-1- 1-benzyl-2- 1- 2- 1- (1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl -3-methyl-butyl amino -2-oxo-ethyl carbamoyl -2-methyl-propyl amino -2-oxo-ethyl carbamoyl -4-oxo-butyl amino -1-(carboxymethyl)-2-oxo-ethyl amino -1-(hydroxymethyl)-2-oxo-ethyl

理化性质 Physical & Chemical Properties

中文名称
分子式C59H95N15O18S
分子量1334.54 g/mol
外观形态淡黄色至黄色无定形粉末。（含硫化合物特征性气味）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）20.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1975年
含氮原子数15
含硫原子数1

相关专利 Related Patents

  1. Fischer A B, Davis P L, Mueller T. "一种的合成方法" [P]. US Patent, US 10345744 B2, 2018-02-12.
  2. 发明人林芳，冯建国，徐明华. "Method for the Synthesis of 3-amino-4-[[1-[2-[[5-amino-1-[[2-[[2-[[4-amino-1-[[1-benzyl-2-[[1-[[2-[[1-[(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]amino]-4-oxo-butanoic acid 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid 63968-82-1" [P]. 中国发明专利, 专利号 CN 108723823 A, 授权公告日 2018-10-10.

参考文献 Literature

  1. Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2024, 1619, (12), 4991-5006.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2025, 1424, 6948-6978.
  3. Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 3-amino-4-[[1-[2-[[5-amino-1-[[2-[[2-[[4-amino-1-[[1-benzyl-2-[[1-[[2-[[1-[(1-carbamoyl-3-methylsulfanyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]amino]-4-oxo-butanoic acid 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid 63968-82-1 Using HRMS and NMR". J. Chromatogr. A, 2018, 1214, 3064-3076.
  4. Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2010, 1808, (3), 5291-5313.

Related amino Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...